Target intelligence / Profile preview

Human Immunodeficiency Virus Viral Infectivity Factor Protein (Vif)

Target
Vif
Molecular classification
Viral protein
01

Overview

The viral infectivity factor (Vif) is an accessory protein encoded by HIV-1 and HIV-2, essential for efficient viral replication in non-permissive cells. Vif counteracts the antiviral activity of APOBEC3 family proteins by inducing their ubiquitination and proteasomal degradation. It also interacts with TP53 to induce G2 cell cycle arrest. Because it antagonizes key innate immune defenses, Vif represents an attractive target for antiretroviral drug development.

02

Mechanism of action

Ubiquitin-mediated degradation of APOBEC3G/F via E3 ligase complex

03

Biological functions

Inhibition of APOBEC3G/F activityUbiquitinationProteasomal degradationG2 cell cycle arrestInhibition of autophagy
04

Disease associations

Infection
05

Safety considerations

Targeting Vif must be carefully considered to avoid unintended consequences related to immune dysregulation.Potential for off-target effects related to TP53 interaction should be investigated.

Beyond the preview

Go deeper on Human Immunodeficiency Virus Viral Infectivity Factor Protein (Vif).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Immunodeficiency Virus Viral Infectivity Factor Protein (Vif).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call